EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:750192 |
| ChEBI Name | belimumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| belimumab (CHEBI:750192) has role anti-inflammatory agent (CHEBI:67079) |
| belimumab (CHEBI:750192) has role antineoplastic agent (CHEBI:35610) |
| belimumab (CHEBI:750192) has role antirheumatic drug (CHEBI:35842) |
| belimumab (CHEBI:750192) has role immunosuppressive agent (CHEBI:35705) |
| belimumab (CHEBI:750192) has role nephroprotective agent (CHEBI:76595) |
| belimumab (CHEBI:750192) has role renoprotective agent (CHEBI:231911) |
| belimumab (CHEBI:750192) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| BEL-114333 | ChEMBL |
| BEL114333 | ChEMBL |
| Belimumab | ChEMBL |
| Belimumab (genetical recombination) | ChEMBL |
| GSK-1550188 | ChEMBL |
| GSK1550188 | ChEMBL |
| Brand Names | Source |
|---|---|
| Benlysta | ChEMBL |
| Lymphostat-b | ChEMBL |
| Lymphostat-b benlysta | ChEMBL |